[July 29, 2016] |
|
Global Casein Kinase 2 Inhibitors Pipeline Insights Report 2016 - Research and Markets
Research and Markets has announced the addition of the "Casein
Kinase 2 Inhibitors -Pipeline Insights, 2016" report to their
offering.
Casein Kinase 2 Inhibitors-Pipeline Insights, 2016 provides in depth
insights on the pipeline drugs and their development activities around
the Casein Kinase 2 Inhibitors. The report covers the product profiles
in various stages of development including Discovery, Pre-clinical, IND,
Phase I, Phase II, Phase III and Preregistration.
Report covers the product clinical trials information and other
development activities including technology, licensing, collaborations,
acquisitions, fundings, patent and USFDA & EMA (News - Alert) designations details.
The report also provides detailed information on the discontinued and
dormant drugs that have gone inactive over the years for Casein Kinase 2
Inhibitors.
The report also assesses the Casein Kinase 2 Inhibitors therapeutics by
Monotherapy, Combination products, molecule type and Route of
Administration.
Scope
-
The report provides competitive pipelie landscape of Casein Kinase 2
Inhibitors
-
The report provides pipeline products under drug profile section which
includes product description, MOA, licensors & collaborators,
development partner and chemical information
-
Coverage of the Casein Kinase 2 Inhibitors pipeline on the basis of
target, MOA, route of administration, technology involved and molecule
type
-
The report reviews key players involved in the therapeutics
development for Casein Kinase 2 Inhibitors and also provide company
profiling
-
The report also gives the information of dormant and discontinued
pipeline projects
-
Pipeline products coverage based on various stages of development
ranging from preregistration till discovery and undisclosed stages
-
Provides pipeline assessment by monotherapy and combination therapy
products, stage of development and molecule type
Key Topics Covered:
-
Overview
-
Pipeline Therapeutics
-
Therapeutics under Development by Companies
-
Filed and Phase III Products
-
Comparative Analysis
-
Phase II Products
-
Comparative Analysis
-
Phase I and IND Filed Products
-
Comparative Analysis
-
Discovery and Pre-Clinical Stage Products
-
Comparative Analysis
-
Drug Candidate Profiles
-
Therapeutics Assessment
-
Assessment by Monotherapy Products
-
Assessment by Combination Products
-
Assessment by Route of Administration
-
Assessment by Molecule Type
-
Discontinued Products
-
Dormant Products
-
Companies Involved in Therapeutics Development
For more information visit http://www.researchandmarkets.com/research/4jtw6g/casein_kinase_2
View source version on businesswire.com: http://www.businesswire.com/news/home/20160729005748/en/
[ Back To TMCnet.com's Homepage ]
|